T. Rowe Price Associates’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-114,100
| Closed | -$67K | – | 3094 |
|
|
2024
Q3 | $67K | Buy |
114,100
+51,400
| +82% | +$28.8K | ﹤0.01% | 2891 |
|
|
2024
Q2 | $39K | Sell |
62,700
-24,127
| -28% | -$20.4K | ﹤0.01% | 2881 |
|
|
2024
Q1 | $224K | Buy |
86,827
+3,338
| +4% | +$8.16K | ﹤0.01% | 2563 |
|
|
2023
Q4 | $171K | Buy |
83,489
+2,954
| +4% | +$5.39K | ﹤0.01% | 2596 |
|
|
2023
Q3 | $139K | Buy |
80,535
+15,800
| +24% | +$28.1K | ﹤0.01% | 2594 |
|
|
2023
Q2 | $127K | Buy |
64,735
+17,835
| +38% | +$41.8K | ﹤0.01% | 2644 |
|
|
2023
Q1 | $131K | Buy |
46,900
+9,600
| +26% | +$27.4K | ﹤0.01% | 2636 |
|
|
2022
Q4 | $129K | Hold |
37,300
| – | – | ﹤0.01% | 2663 |
|
|
2022
Q3 | $96K | Hold |
37,300
| – | – | ﹤0.01% | 2740 |
|
|
2022
Q2 | $90K | Sell |
37,300
-3,799
| -9% | -$9.98K | ﹤0.01% | 2777 |
|
|
2022
Q1 | $169K | Buy |
41,099
+12,143
| +42% | +$64.3K | ﹤0.01% | 2749 |
|
|
2021
Q4 | $372K | Sell |
28,956
-2,188
| -7% | -$24.2K | ﹤0.01% | 2520 |
|
|
2021
Q3 | $336K | Sell |
31,144
-172,726
| -85% | -$1.57M | ﹤0.01% | 2541 |
|
|
2021
Q2 | $1.86M | Sell |
203,870
-107,625
| -35% | -$995K | ﹤0.01% | 1770 |
|
|
2021
Q1 | $2.94M | Buy |
+311,495
| New | +$4.29M | ﹤0.01% | 1588 |
|
|
2020
Q3 | – | Sell |
-371,757
| Closed | -$2.47M | – | 2633 |
|
|
2020
Q2 | $2.47M | Sell |
371,757
-35,565
| -9% | -$240K | ﹤0.01% | 1491 |
|
|
2020
Q1 | $2.37M | Buy |
407,322
+207,551
| +104% | +$1.74M | ﹤0.01% | 1466 |
|
|
2019
Q4 | $1.79M | Buy |
+199,771
| New | +$1.67M | ﹤0.01% | 1640 |
|
Other funds holding GRTS
T. Rowe Price Associates's GRTS Position: Q4 2024 in Review
T. Rowe Price Associates sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 114,100 shares — an estimated $67K sold.
T. Rowe Price Associates first reported a position in GRTS in Q4 2019 and held it in 18 quarters. The position peaked at $2.94M in Q1 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- T. Rowe Price Associates reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- T. Rowe Price Associates sold 114,100 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $67K.
- T. Rowe Price Associates first reported a position in Gritstone bio, Inc. Common Stock in Q4 2019 and held it in 18 quarters.
- T. Rowe Price Associates's Gritstone bio, Inc. Common Stock position peaked at $2.94M in Q1 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.